Specialists from the Central Institute of Traumatology and Orthopedics of the Rostec State Corporation have developed and implemented a unique medical device for the treatment of joint diseases. This device, which has no analogues in Russia, can effectively replace imported counterparts and ensure bone restoration in case of defects. The first operation using the new development was successful.
The endosystem was created by a team of CITO engineers in collaboration with surgeons. In terms of its technical parameters, it is comparable to foreign analogues.
The system includes a titanium prosthesis and additional components that help compensate for bone defects. They guarantee strong fixation and fusion with bone tissue.
In Russia, about 170,000 knee and hip joint replacement surgeries are performed annually. Of these, 10-15% are secondary operations to replace the endoprosthesis. With the departure of foreign manufacturers of medical devices, including those for joint replacement, our priority has become the creation of domestic equipment and materials.
The endosystem created at CITO is the first domestic import-substituted product designed to replace endoprostheses that have lasted more than 15 years. According to experts, the demand for this product will exceed 135,000 units in the next 10 years.
The first operation using the innovative endosystem was performed on an elderly woman. During the operation, a complex reconstructive intervention was performed, including the installation of a hip endoprosthesis and the restoration of the femur and acetabulum. The operation lasted three hours and was without complications.
The patient was able to walk the day after the operation. She plans to return to her work as a district nurse in the near future.
During the surgical intervention, original instruments and an endoprosthesis were used, which we developed jointly with CITO specialists. This product has come a long way from development to obtaining a registration certificate. My personal feeling as a surgeon with extensive experience in this field is that our implant, in terms of instrumentation and technical characteristics, is comparable to imported analogues.
CITO has been developing and manufacturing endoprostheses since April 2021. As a result of this activity, innovative solutions are being created in the field of orthopedics.
In 2024, hip endoprostheses and instruments for their installation were included in the State Register of Medical Devices. This confirms that CITO products meet all necessary safety and efficacy requirements.
Earlier, Rosatom developed a biofabricator for growing human tissues. It can be used to simulate processes at the micro level.
Read more on the topic:
A robotic arm was created in Samara for printing tissues and cartilage during surgery
Russian scientists have developed a prosthesis capable of imitating tactile sensations
